Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
      Google Scholar   
Citation:
Breast Cancer Res Treat
Year:
2025
Type:
Manuscript
Funding:
AFT
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3639  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT, Austrian Breast and Colorectal Cancer Study Group (ABCSG-42), PrECOG, BIG, GBG, NSABP  
Corr. Author:
 
Authors:
                                                                                       
Networks:
LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-PA015, LAPS-TX035   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: